It’s difficult to imagine anyone launching a biotech company in anticipation of it stalling and becoming a turnaround three or five years later. Still, many companies find themselves just a few years after launch in a position where growth (if there was any) has stagnated and raising capital is increasingly difficult. In our experience there are three reasons why biotech turnarounds are so hard.
What are some practical methods that can accelerate your biotech start-up? Most of these tips center on conserving cash at the early stage (seed rounds) by avoiding unnecessary outlays. After all, if your business can’t survive the seed rounds, what is the point?
Marketing clutter accumulates the same as the detritus in a teenager’s room. Worn tactics are tossed about the floor, taking up valuable space. The laundry basket is overflowing with campaigns that have outlived their usefulness but nobody really wants to take the initiative to clean them up. Out dated materials for sales reps are littered about, like old homework assignments. It's time to declutter!